(Q84346983)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19654068%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

title

Influence of the route of administration on immunomodulatory properties of bovine beta-lactoglobulin-producing Lactobacillus casei (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19654068%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

main subject

Lacticaseibacillus casei

object named as

Lactobacillus casei

1 reference

S Hazebrouck

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19654068%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

L Przybylski-Nicaise

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19654068%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

S Ah-Leung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19654068%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

K Adel-Patient

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19654068%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

G Corthier

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19654068%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

P Langella

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19654068%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

J-M Wal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19654068%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

3 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19654068%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19654068%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19654068%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19654068%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

5800-5805

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19654068%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Maintenance of tolerance to cow's milk in atopic individuals is characterized by high levels of specific immunoglobulin G4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Clinical course and prognosis of cow's milk allergy are dependent on milk-specific IgE status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Family size, infection and atopy: the first decade of the "hygiene hypothesis".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

The intrauterine and postnatal environments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Probiotics for the prevention or treatment of allergic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Potential and opportunities for use of recombinant lactic acid bacteria in human health

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Oral administration of recombinant Lactococcus lactis expressing bovine beta-lactoglobulin partially prevents mice from sensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Induction of mucosal immune response after intranasal or oral inoculation of mice with Lactococcus lactis producing bovine beta-lactoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Efficient production and secretion of bovine beta-lactoglobulin by Lactobacillus casei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Two-site enzyme immunometric assays for determination of native and denatured beta-lactoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Evaluation of a high IgE-responder mouse model of allergy to bovine beta-lactoglobulin (BLG): development of sandwich immunoassays for total and allergen-specific IgE, IgG1 and IgG2a in BLG-sensitized mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Production of monoclonal antibodies against interleukin-1 alpha and -1 beta. Development of two enzyme immunometric assays (EIA) using acetylcholinesterase and their application to biological media

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Initiation of protein synthesis by a labeled derivative of the Lactobacillus casei DN-114 001 strain during transit from the stomach to the cecum in mice harboring human microbiota

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Growth phase of orally administered Lactobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: implications for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

The future of antigen-specific immunotherapy of allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Anti-inflammatory effects of Lactobacillus casei BL23 producing or not a manganese-dependant catalase on DSS-induced colitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Differentiation and function of Th17 T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Microbial lipopeptides induce the production of IL-17 in Th cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

CD11b facilitates the development of peripheral tolerance by suppressing Th17 differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic bacteria: involvement of toll-like receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Total and allergen-specific immunoglobulin A levels in saliva in relation to the development of allergy in infants up to 2 years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

Survival, physiology, and lysis of Lactococcus lactis in the digestive tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.07.064

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2009.07.064

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19654068%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1 reference